TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: “…In Case Mrs. Lasker Happens To See A Senator”; White Potter Defend Center Progress June 16, 1978
TCL Archive Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says October 29, 1999
